HalesMeds

Review by eFreeware

Most medical reference apps try to cover everything. HalesMeds does the opposite: it is built around one clinical question, whether a drug is safe for a breastfeeding mother and her infant. That narrowness is the point. The app carries lactation risk categories for more than 1,300 drugs, diseases, vaccines and syndromes, and it comes from Springer Publishing with content credited to Dr. Thomas W. Hale and PharmD Kaytlin Krutsch.

That focus tells you who it is for. This is a working tool for clinicians, lactation consultants and prescribers who field questions about medication safety during breastfeeding and need a defensible answer quickly. It is not a general drug encyclopedia.

The app has been on Google Play since June 2018 and has been updated as recently as March 2026, which matters for a reference that has to keep pace with new drugs. It sits in the Medical category, is free to download, and carries a 3.3 average from 28 ratings.

The lactation risk category is the core of the app

Everything in HalesMeds hangs on the lactation risk category, or LRC, attached to each entry. Rather than leaving you to interpret raw pharmacology, the app assigns a category you can read at a glance and use to judge whether a drug is hazardous for a breastfeeding patient. For a clinician making a call during a consultation, that single value is a quick reference point.

The catalog is broader than the name suggests. Alongside medications, it covers diseases, vaccines and syndromes, so the same lookup can answer questions that are not strictly about a prescription. The developer has also added newer entries, including weight loss drugs such as Ozempic and Wegovy, heart failure drugs like Entresto, and medications for anxiety and postpartum depression.

That last group is telling. Postpartum depression treatment and breastfeeding are exactly the situation where a parent and a prescriber need a clear answer. The developer describes the content as evidence-based and continuously revised, drawing on research into how maternal drugs pass into human milk.

Search, dosing details and safer alternatives

Finding an entry is handled two ways: a quick search and an alphabetical lookup. These conveniences matter when you are looking something up mid-conversation and do not want to scroll.

Each entry goes further than the risk category. The app provides adult concerns, adult dose, pediatric concerns and infant monitoring, so you can see not just whether a drug is flagged but what to watch for in the nursing infant and what the adult dose looks like. There is also succinct information on evaluating the infant, which supports the monitoring side of the decision.

For entries that come out high-risk, HalesMeds suggests safer alternatives. That turns a negative answer into something actionable for the prescriber. Breastfeeding and medication tips and key points are also covered.

What full access costs

HalesMeds is free to download and shows no ads, but full access runs through a subscription. The developer lists two terms: one month at $7.99, and a yearly option at $84.99 for twelve months. Those prices are quoted for United States customers, and the developer notes that pricing elsewhere may differ and that charges may be converted into your local currency.

The subscriptions renew automatically. Your card is charged at the end of each term unless auto-renew is switched off at least 24 hours before the current period ends, and you can turn renewal off from your account settings. Refunds are not given for unused portions of a term, and any unused part of a free trial is forfeited once a subscription is purchased.

For a clinician who uses it regularly, the annual term works out cheaper per month than the monthly one; for someone checking a handful of cases, the monthly term is the lower commitment.

How it fits into a clinical workflow

The natural use is a specific question at a specific moment: a breastfeeding patient is prescribed something, and you need to know whether it is compatible and what to monitor. The risk category gives the headline, the adult and pediatric concerns give the context, and the alternatives give you a next step if the answer is unfavorable.

It also works as a teaching and counseling aid. Because entries carry key points and tips, they can be read aloud or paraphrased when explaining a decision to a parent who is anxious about taking medication while nursing.

I would treat it as a companion to your existing references rather than a replacement for clinical judgment. The app organizes evidence and expert assessment; the decision about a particular patient still rests with the prescriber.

The app has been maintained over a long stretch, with the most recent update in March 2026. Installs sit at over 10,000.

A reference for lactation questions, not general prescribing

HalesMeds is a focused lactation drug reference, and it should be judged as one. It answers a narrow, high-stakes question well: is this drug safe during breastfeeding, and if not, what else could be used? The catalog of more than 1,300 entries, the risk categories, the monitoring details and the alternative suggestions all serve that single purpose.

It suits clinicians, lactation consultants and prescribers who deal with breastfeeding patients and want a fast, structured answer backed by named experts and a publisher with a stake in the content.

The caveats are straightforward. The content is medical reference material aimed at professionals rather than a consumer guide. The 3.3 average from 28 ratings is a small sample.

A worthwhile subscription for lactation-focused clinicians

If lactation safety questions are a regular part of your work, HalesMeds is the kind of reference that earns a place on your phone. The lactation risk category, the adult and pediatric concerns, the infant monitoring guidance and the safer-alternative suggestions are all part of the app.

If you only occasionally need this information, the monthly term is the sensible way to try it before committing to a year.

This is a specialist tool for people who already know why they need it. For that audience, the combination of a named editorial team, a publisher behind the content and a long update history is notable.